A multicentre phase III randomised double blind placebo contolled trial of pravastatin added to first-line standard chemotherapy in patients with small cell lung cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Pravastatin (Primary) ; Carboplatin; Cisplatin; Etoposide; Etoposide
- Indications Small cell lung cancer
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms LungStar
- 03 Dec 2014 Biomarkers information updated
- 15 Jan 2013 Planned end date changed from 31 Dec 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.
- 31 May 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.